Overview
One of the most significant medical advances in the past 20 years is the discovery of agents that target the specific molecules that control cell growth or blood supply to cancerous tumors. Using targeted therapies alone or in combination with other pharmaceutical, radiologic, or surgical interventions has significantly improved survival, decreased adverse events, and improved quality of life for patients with cancer.
Applications for this fellowship program are welcome from institutions and programs that focus on educating clinicians on the diagnosis, individualized treatment, and supportive care of patients with neoplastic disorders (hematologic or solid tumors).
Program Design
Ten awards for up to $100,000 each, paid at $50,000 over 2 years
Eligibility
Institutions
Must be an accredited academic institution.
Requirements
Funding must be used primarily as salary support for the selected fellow, not for overhead, indirect, or fringe costs.
The institution cannot host another recipient of this same award during the proposed term as an awardee.
Fellows
The selected fellow should have relevant experience and be eligible for an appointment as a postdoctoral fellow/trainee at a US-based academic medical center.
At least 50% of the fellow’s time will be devoted to clinical work.
The selected fellow must be a US citizen or foreign national with permanent US residence.
More than 1 application per academic institution may be submitted, provided that each application is from a different department/division. The applicant cannot be mentored by, nor have a familial relationship with, a member of the 2011 Academic Advisory Board. The applicant cannot be awarded if his or her institution will be hosting another recipient of this same award during the proposed term as an awardee.
Application Components
Applicants must provide the following components:
- Detailed description of the fellowship program
- Outline of the proposed rotations/clinical assignments
- Letters of support from the Dean/ Division Head/ Department Chair
- CV/ Bios
- Department/ Division Head/ Department Chair
- Primary mentor; secondary mentor (if applicable)
- Co-investigators for the proposed research (if applicable)
-Address additional sources of financial support for this proposal, including current and pending sources of funding
Application Deadline: February 11, 2011
Contact Us
Questions about the programs and/or applications:
The Pfizer MAP Team
Phone: (877) 254-6953
E-mail: MAPinfo@clinicalconnexion.com
Pfizer colleague questions regarding funding fellowships:
Carmine Novembre, MPH, CPH
Director, External Medical Affairs
E-mail: carmine.novembre@pfizer.com
http://www.pfizerfellowships.com/AwardDetails.aspx?AwardID=2266
Please kindly mention Scholarization.blogspot.com when applying for this fellowship
One of the most significant medical advances in the past 20 years is the discovery of agents that target the specific molecules that control cell growth or blood supply to cancerous tumors. Using targeted therapies alone or in combination with other pharmaceutical, radiologic, or surgical interventions has significantly improved survival, decreased adverse events, and improved quality of life for patients with cancer.
Applications for this fellowship program are welcome from institutions and programs that focus on educating clinicians on the diagnosis, individualized treatment, and supportive care of patients with neoplastic disorders (hematologic or solid tumors).
Program Design
Ten awards for up to $100,000 each, paid at $50,000 over 2 years
Eligibility
Institutions
Must be an accredited academic institution.
Requirements
Funding must be used primarily as salary support for the selected fellow, not for overhead, indirect, or fringe costs.
The institution cannot host another recipient of this same award during the proposed term as an awardee.
Fellows
The selected fellow should have relevant experience and be eligible for an appointment as a postdoctoral fellow/trainee at a US-based academic medical center.
At least 50% of the fellow’s time will be devoted to clinical work.
The selected fellow must be a US citizen or foreign national with permanent US residence.
More than 1 application per academic institution may be submitted, provided that each application is from a different department/division. The applicant cannot be mentored by, nor have a familial relationship with, a member of the 2011 Academic Advisory Board. The applicant cannot be awarded if his or her institution will be hosting another recipient of this same award during the proposed term as an awardee.
Application Components
Applicants must provide the following components:
- Detailed description of the fellowship program
- Outline of the proposed rotations/clinical assignments
- Letters of support from the Dean/ Division Head/ Department Chair
- CV/ Bios
- Department/ Division Head/ Department Chair
- Primary mentor; secondary mentor (if applicable)
- Co-investigators for the proposed research (if applicable)
-Address additional sources of financial support for this proposal, including current and pending sources of funding
Application Deadline: February 11, 2011
Contact Us
Questions about the programs and/or applications:
The Pfizer MAP Team
Phone: (877) 254-6953
E-mail: MAPinfo@clinicalconnexion.com
Pfizer colleague questions regarding funding fellowships:
Carmine Novembre, MPH, CPH
Director, External Medical Affairs
E-mail: carmine.novembre@pfizer.com
http://www.pfizerfellowships.com/AwardDetails.aspx?AwardID=2266
Please kindly mention Scholarization.blogspot.com when applying for this fellowship
0 comments:
Post a Comment